Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
Invesco India Pharma And Healthcare Fund icon

Invesco India Pharma And Healthcare Fund

Sectoral-Pharma
Not Rated

NAV (2026-10-07)

₹9.44

AUM

₹438.54 Cr

Exp. Ratio: 5.19%

RISK LEVEL

Very High

Returns & Performance

1 Year----
3 Year----
5 Year----
Since Launch-5.60%22.54% vs cat avg

Fund vs Category Average

Pros & Cons

Pros

✔No lock-in period

Cons

✖1Y returns trail category average
✖3Y returns below category average
✖Higher expense ratio (5.19%)
✖Returns since launch below category avg
ISININF205KA1BU1
NAV₹9.44
NAV Date2026-10-07
AUM₹438.54 Cr
Expense Ratio5.19%
RiskVery High
RatingNot Rated / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Exit Load0.50%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Aditya Khemani

Mr. Khemani has done B.Com (Hons) and PGDM from IIM, Lucknow.

Prior to joining Invesco Mutual Fund, He was associated with Motilal Oswal Mutual Fund, HSBC AMC, SBI Mutual Fund, ICICI Prudential AMC and Morgan Stanley Advantage Services.

Top Holdings

Holdings data not available for this scheme

Frequently Asked Questions

Common questions about this fund, answered from scheme data

The latest Net Asset Value (NAV) of Invesco India Pharma And Healthcare Fund is ₹9.44 as of 2026-10-07.

The FAQs above are generated from data provided by the AMC and are for educational purposes only. They do not constitute financial advice, buy/sell recommendations, or return guarantees. Mutual fund investments are subject to market risks — read all scheme-related documents carefully before investing. Past performance is not indicative of future returns.